Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-08

Clinical Trial Update: Nicotinamide in the Treatment of Psoriasis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluating nicotinamide for treating psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide (nicotinamide)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Psoriasis | Phase 2, Phase 3 | Status: COMPLETED